recentpopularlog in

pharmacy

« earlier   
Hydroxychloroquine COVID-19 Drug Interactions - EM PharmD
Hydroxychloroquine COVID-19 Drug Interactions. Learn about how you can protect patients from long term impact of drug interactions for treating corona virus
pharmacy 
19 days ago by jessrademacher
Prescription Prices, Coupons & Pharmacy Information - GoodRx
Compare prescription drug prices and find coupons at more than 60,000 US pharmacies. Save up to 80% instantly!
pharmacy  prescription 
8 weeks ago by squires
Losing Access to Care: Your Pharmacy is Closing | LLU Institute for Health Policy Leadership
Many folks who have a minor ailment, a question about medicines, or a health concern in general often stop by their local pharmacy to ask the pharmacist for advice. I grew up in a rural area of Southern Illinois that did not have a full-time physician. The health department clinic was only open on select mornings each week to administer vaccines. The pharmacist was the only healthcare professional that my family could easily see within 30 miles.
Regardless of where we live, we’ve likely taken for granted that there is a pharmacy nearby. Today those pharmacies are often owned by CVS or Walgreens or are situated in a grocery store or big box retailer like Wal-Mart, Costco or Target. Health systems like Loma Linda University Health also own community pharmacies. There are still nearly 22,000 privately owned pharmacies in the U.S.1
pharmacy  business  economics  health  drugs  community 
9 weeks ago by rgl7194
How Chaos at Chain Pharmacies Is Putting Patients at Risk - The New York Times
Pharmacists across the U.S. warn that the push to do more with less has made medication errors more likely. “I am a danger to the public,” one wrote to a regulator.
For Alyssa Watrous, the medication mix-up meant a pounding headache, nausea and dizziness. In September, Ms. Watrous, a 17-year-old from Connecticut, was about to take another asthma pill when she realized CVS had mistakenly given her blood pressure medication intended for someone else.
Edward Walker, 38, landed in an emergency room, his eyes swollen and burning after he put drops in them for five days in November 2018 to treat a mild irritation. A Walgreens in Illinois had accidentally supplied him with ear drops — not eye drops.
For Mary Scheuerman, 85, the error was discovered only when she was dying in a Florida hospital in December 2018. A Publix pharmacy had dispensed a powerful chemotherapy drug instead of the antidepressant her doctor had prescribed. She died about two weeks later.
The people least surprised by such mistakes are pharmacists working in some of the nation’s biggest retail chains.
In letters to state regulatory boards and in interviews with The New York Times, many pharmacists at companies like CVS, Rite Aid and Walgreens described understaffed and chaotic workplaces where they said it had become difficult to perform their jobs safely, putting the public at risk of medication errors.
They struggle to fill prescriptions, give flu shots, tend the drive-through, answer phones, work the register, counsel patients and call doctors and insurance companies, they said — all the while racing to meet corporate performance metrics that they characterized as unreasonable and unsafe in an industry squeezed to do more with less.
“I am a danger to the public working for CVS,” one pharmacist wrote in an anonymous letter to the Texas State Board of Pharmacy in April.
“The amount of busywork we must do while verifying prescriptions is absolutely dangerous,” another wrote to the Pennsylvania board in February. “Mistakes are going to be made and the patients are going to be the ones suffering.”
business  pharmacy  monopoly  nytimes  health  drugs  insurance  PBM  politics  gov2.0  safety 
9 weeks ago by rgl7194
How CVS Became A Health Care Tyrant - BIG by Matt Stoller
Hi,
Welcome to BIG, a newsletter about the politics of monopoly. If you’d like to sign up, you can do so here. Or just read on…
Today I’ll go over an important story in the New York Times by Ellen Gabler about the giant American drug store chain and health care company CVS. First, some housekeeping. For those in D.C., I’ll be speaking at Solid State books next Tuesday at 7pm about my book Goliath. And yesterday I was on NPR’s Marketplace talking about the cheerleading monopoly.
And now…
CVS: A Sweatshop for Pharmacists
Very few people realize that the third leading cause of death in America is medical errors, at between 250,000 and 440,000 people a year. That’s a population the size of Reno, Nevada dying every single year. Some of these deaths are unavoidable, as mistakes are a fact of life, but the powerful monopolies in American health care system do two things to contribute to such mistakes. First, they push too many high-margin but unnecessary pills and surgeries, and second, they interfere in the relationship between medical professionals and patients.
Ellen Gabler at the New York Times had a great story yesterday with the gory details of one such example, the massive drug store chain CVS. The gist of her story is that CVS has imposed sweatshop-style conditions in their stores. Pharmacies are understaffed, pharmacists don’t have time to focus on patients (or sometimes even take bathroom breaks), and they are constantly being pressed to overprescribe medication.
The article has a litany of horrible errors, including a patient dying because she accidentally got dispensed harsh chemotherapy drugs, or a baby accidentally receiving steroids. As Gabler showed, “doctors complain that pharmacies bombard them with requests for refills that patients have not asked for and should not receive.”
Pharmacists themselves are frustrated. “I am a danger to the public working for CVS,” wrote one pharmacist the Texas State Board of Pharmacy in April. A different one told authorities in Pennsylvania that because of these practices, “Mistakes are going to be made and the patients are going to be the ones suffering.”
business  pharmacy  monopoly  nytimes  health  drugs  insurance  PBM  politics  gov2.0  safety  BIG 
9 weeks ago by rgl7194
Goldman Sachs Asks: ‘Is Curing Patients A Sustainable Business Model?’ | Above the Law
In April, reports surfaced that analysts from Goldman Sachs asked, “Is curing patients a sustainable business model?” This is a terrible question for so many reasons, but as I detail further below, this question reveals that many companies really have only one goal and how inadequate our current patent system is in incentivizing public goods.

Goldman Sachs basically concluded that, from a business perspective, curing patients will result in less revenue compared to ongoing, chronic treatments. Using pharmaceutical company Gilead’s treatment for hepatitis C as an example, Goldman Sachs noted that sales for the treatment peaked at $12.5 billion in 2015, but have been declining since then and is projected at less than $4 billion for 2018. The reason, of course, is that a successful cure “exhaust[s] the available pool of treatable patients” and therefore “could represent a challenge for genome medicine developers looking for sustained cash flow.” The analyst went on to note that curing an infectious disease “also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also declines,” further leading to a decreased need for the treatment.
pharmacy  medical  cure  disease  profit 
10 weeks ago by Quercki
ATC CARE, LLC - NYS Department of State Division of Corporations Entity Information
NYS Department of State
Division of Corporations
Entity Information
The information contained in this database is current through January 24, 2020.
Selected Entity Name: ATC CARE, LLC
Selected Entity Status Information
Current Entity Name: ATC CARE, LLC
DOS ID #: 3372241
Initial DOS Filing Date: JUNE 06, 2006
County: MONROE
Jurisdiction: NEW YORK
Entity Type: DOMESTIC LIMITED LIABILITY COMPANY
Current Entity Status: ACTIVE
Selected Entity Address Information
DOS Process (Address to which DOS will mail process if accepted on behalf of the entity)
ATC CARE, LLC
FAIRPORT PHARMACY
650 WHITNEY ROAD, SUITE K
FAIRPORT, NEW YORK, 14450
Registered Agent
NONE
This office does not require or maintain information regarding the names and addresses of members or managers of nonprofessional limited liability companies. Professional limited liability companies must include the name(s) and address(es) of the original members, however this information is not recorded and only available by viewing the certificate.
*Stock Information
# of Shares Type of Stock $ Value per Share
  No Information Available  
*Stock information is applicable to domestic business corporations.
Name History
Filing Date Name Type Entity Name
JUN 06, 2006 Actual ATC CARE, LLC
A Fictitious name must be used when the Actual name of a foreign entity is unavailable for use in New York State. The entity must use the fictitious name when conducting its activities or business in New York State.
NOTE: New York State does not issue organizational identification numbers.
business  pharmacy  gov2.0  database  new_york 
10 weeks ago by rgl7194
Johnson & Johnson opioid trial: Oklahoma wins historic case against drugmaker - CNN
(CNN)In a landmark decision, an Oklahoma judge on Monday ordered pharmaceutical giant Johnson & Johnson to pay $572 million for its role in the state's opioid crisis.
The verdict issued by Cleveland County District Judge Thad Balkman marks the end of the first state trial attempting to hold a pharmaceutical company accountable for one of the worst health epidemics in history. In his ruling, Balkman said the opioid crisis has "ravaged" the state of Oklahoma.
The defendants "engaged in false and misleading marketing of both their drugs and opioids generally, and the law makes clear that such conduct is more than enough to serve as the act or omission necessary to establish the first element of Oklahoma's public nuisance law," Balkman wrote in his ruling (PDF).
Following the ruling, Johnson & Johnson announced that it plans to appeal the "flawed" judgment.
"Janssen did not cause the opioid crisis in Oklahoma, and neither the facts nor the law support this outcome," Michael Ullmann, executive vice president and general counsel for Johnson & Johnson, said in a written statement on Monday.
"We recognize the opioid crisis is a tremendously complex public health issue and we have deep sympathy for everyone affected. We are working with partners to find ways to help those in need," he said. "This judgment is a misapplication of public nuisance law that has already been rejected by judges in other states."
opioids  drugs  big_pharma  pharmacy  crime  legal  gov2.0  money 
11 weeks ago by rgl7194

Copy this bookmark:





to read